PROVIDER PROFILE · NPI 1609414218

Ruby Nzoma

MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
11
Beneficiaries
Total drug cost
$43K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Cabotegravir11 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.